<html>
<head>PUBMED IDs for PDZRN3</head>
<body bgcolor='#C5F0F2'><h1>PDZRN3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15010864/'>Identification and characterization of PDZRN3 and PDZRN4 genes in silico.</a> March 11  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15138636/'>Identification and characterization of human PDZRN4L gene and mouse Pdzrn4l gene in silico.</a> May 13  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/17118964/'>PDZRN3 (LNX3, SEMCAP3) is required for the differentiation of C2C12 myoblasts into myotubes.</a> November 23  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17912030/'>Copy-number variants in patients with a strong family history of pancreatic cancer.</a> October 4  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19864897/'>Characterization of a 5.8-Mb interstitial deletion of chromosome 3p in a girl with 46,XX,inv(7)dn karyotype and phenotypic abnormalities.</a> November 10  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20633763/'>Molecular analysis of germline t(3;6) and t(3;12) associated with conventional renal cell carcinomas indicates their rate-limiting role and supports the three-hit model of carcinogenesis.</a> July 30  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22664479/'>A genome-wide association study for irinotecan-related severe toxicities in patients with advanced non-small-cell lung cancer.</a> May 3  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/25651471/'>Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications.</a> September 1  2015<br></body></html>
